News

The vaccine candidate, PEV4 is a modern subunit vaccine against respiratory syncytial virus (RSV), which is based on a recombinant RSV-F protein formulated with Pevion Biotech’s proprietary and

Ocimum Biosolutions said that qRT-PCR technology is routinely used for various applications such as expression analysis of candidate genes, validation of microarrays, gene copy number determination and target

The QuantiFERON-CMV (QF-CMV), is the commercially-available blood test to allow physicians to monitor a person’s risk of CMV disease. Most commonly used in the transplant setting, QF-CMV may

Alcon posted a net income of $573m for the first quarter 2010, or $1.89 per diluted share, compared to $452m, or $1.51 per diluted share, for the prior

As per the agreement, Anacor will be responsible for leading the research effort and MMV will contribute its extensive malaria drug research expertise as well as financial support.

The project, which is worth $2m, is expected to be operational on January 1, 2011. Ness Technologies will support the project through the end of April 2011. The

The FDA has approved Asclera (polidocanol) injection on March 30, 2010 to sclerose uncomplicated spider veins (varicose veins less than or equal to 1mm in diameter) and uncomplicated

Proteo’s drug substance Elafin is a natural human antagonist of elastase and proteinase-3, two potent tissue destroying enzymes, both of which participate in the inflammatory mechanism of a

AkzoNobel has posted a net income of EUR81m, or EUR0.35 per diluted share, compared to net loss of EUR7m, or EUR0.03 per diluted share, for the prior year